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Used a population-based sample (Georgia Centenarian Study, GCS), to determine proportions of centenarians reaching 100
years as (1) survivors (43%) of chronic diseases first experienced between 0–80 years of age, (2) delayers (36%) with chronic
diseases first experienced between 80–98 years of age, or (3) escapers (17%) with chronic diseases only at 98 years of age or
older. Diseases fall into two morbidity profiles of 11 chronic diseases; one including cardiovascular disease, cancer, anemia, and
osteoporosis, and another including dementia. Centenarians at risk for cancer in their lifetime tended to be escapers (73%),
while those at risk for cardiovascular disease tended to be survivors (24%), delayers (39%), or escapers (32%). Approximately
half (43%) of the centenarians did not experience dementia. Psychiatric disorders were positively associated with dementia, but
prevalence of depression, anxiety, and psychoses did not diﬀer significantly between centenarians and an octogenarian control
group. However, centenarians were higher on the Geriatric Depression Scale (GDS) than octogenarians. Consistent with our model
of developmental adaptation in aging, distal life events contribute to predicting survivorship outcome in which health status as
survivor, delayer, or escaper appears as adaptation variables late in life.

1. Introduction
With the expected lifespan of humans increasing at a rate of
2.5 years per decade [1], it will not be uncommon for individuals born in developed countries in this decade to live into
the next century (Figure 1(a)) [2]. This observation poses
a substantial challenge to health care and other entitlement
systems because chronic diseases, which are the cause of 60
percent of deaths worldwide, often dictate the conditions of

our later lives. Here we develop a means to predict the healthrelated survivorship outcomes of centenarians entering the
next century.
The GCS obtained a population-based sample of 244
centenarians and near-centenarians (98 years old or older)
and 80 octogenarians [3] through voter registration roles,
and sampling from a complete list of nursing homes (NH)
and personal care homes (PCH) in a 44-county area of
northeast Georgia [3]. The GCS sample was drawn from
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Figure 1: (a) Exponential growth of Centenarians in England over the last century [2]. (b) Network of morbidity in centenarians in the
GCS [3] using lifetime prevalence of 11 most common chronic diseases in the GCS. All pairwise associations that were not significant by an
exact test were set to zero, and the remaining significant (with α = 0.05) pairwise correlations (rxy ) between chronic diseases x and y were all
positive. These significant pairwise positive associations were graphically rendered using the distance 1-rxy and multi-dimensional scaling [9]
to compute coordinates for the chronic diseases. The coordinates were then graphed as a network [10]. COPD denotes chronic pulmonary
obstruction disease. Chronic and acute pneumonia were not distinguished in the medical questionnaire. (c) Average linkage [11] was used
to compute a dendrogram independently relating the 11 chronic diseases based on their pairwise correlations rxy . (d) The distribution of
GDRS scores [12] in centenarians is compared with the distribution of GDRS scores in 80 octogenarians as a control group. A GDRS score
of 4–7 is indicative of dementia, a score of 3, of mild cognitive impairment, and a score of 1-2, as unaﬀected.

counties in 4 strata, which were compared for sample
characteristics with the 2000 US Census in Table 1. There
is a reasonable agreement between the 2000 Census and
the sample in the GCS with a slight under-representation
of African-Americans. Sampling weights were developed
to match sample characteristics with the 2000 Census
profile (see Supplement). Statistical analyses below were
performed with and without these weights with no change
in conclusions. To address appropriately our own successful
aging, we first need to answer the following questions: at 100
years of age, (i) will we be cognitively intact? (ii) what will
be our emotional state? (iii) how likely is it that we will be
coping with a chronic disease [4]? (iv) what chronic diseases
will we need to cope with? (v) when will we experience a
chronic disease?

2. Materials and Methods
The recruitment rate (i.e., the percentage of those participating out of those contacted) was 67.2% for centenarians
and 46.0%, for octogenarians. Data on GCS participants
were collected under Institutional Review Board approval
and Human Subjects consent and are deposited in the
Georgia Centenarian Database [5]. In contrast to Phase
1 and Phase 2 of the GCS, centenarians in Phase 3 here
spanned a wide range of functional capacity from being
bedbound in a nursing home to living independently in
the community [3]. Demographic and medical histories of
GCS participants were collected onto computer generated
questionnaires and completed in 4, ∼2 hour interviews
with GCS participants. Sources for answers on the health
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Table 1: Demographics of 2000 Census in Georgia and GCS study
participants. In (b) and (c) entries for Participants and 2000 Census
are for centenarians and near-centenarians.
(a) Age Distribution, 2000 Census versus GCS Participants

Age
98
99
100–104
105+
TOTAL

Participants
Number
Percent
61
25%
48
20
126
52
9
4
244
100%

2000 Census
Number
Percent
362
30%
275
23
526
42
81
6
1244
100%

(b) Gender Distribution, 2000 Census versus Participants

Participants
Number
Percent
37
15%
207
85
244
100%

Gender
Male
Female
TOTAL

2000 Census
Number
Percent
237
19%
1007
81
1244
100%

(c) Race Distribution, 2000 Census versus Participants

Race
Black
Non-Black
TOTAL

Participants
Number
Percent
52
21%
192
79
244
100%

2000 Census
Number
Percent
397
32%
847
68
1244
100%

questionnaire were participants, their legal proxy, care
professionals in NHs or PCHs, and medical charts at
NHs or PCHs. The health questionnaire included medical
history, current problems (such as, bedbound status, assistive
devices, and restricted activity days), medications/oxygen,
physical examination (including vital signs, skin fold/Arm
Circumference and hand grip, hearing, vision, fine motor
testing, lower leg extension, foot sensory, weight/height, and
shoulder flexion and vision test), EPESE and PPME tests
of functional capacity (including standing balance, 8-foot
walk, chair stands, step-up, and Bed Mobility), gross physical
abnormalities, global assessment of physical health, and GDS
[6]. International Disease Classification 9 (ICD-9) provided
a framework for constructing the health questionnaire.
More details on data collected have been previously given
[3]. The instruments available at http://qa.genetics.uga.edu/
were then scanned into a Teleform database [5], checked,
corrected, and verified and saved as individual pdf images
for loading into the Georgia Centenarian Database [5]. A
serious issue in centenarian studies is age validation [7].
The GCS employed internationally-established criteria in age
verification [8]. The principal guideline is that chronological
age must be validated by convergent multiple and creditable
sources and public records, such as birth and marriage
certificates of the individuals as well as their oﬀspring and
relatives to create a consistent chronology. Driver’s licenses,
Social Security documents, census records, as well as death
records of oﬀspring are used.

3
To validate medical histories on centenarians, nonfasting
blood samples were drawn by a skilled phlebotomist as
previously described [3]. From these blood samples, glycated
hemoglobin (HbA1c) and hemoglobin levels were assessed
by a clinical diagnostic laboratory (LabCorp, Inc., Burlington, NC) and used for diagnosis of diabetes and anemia,
respectively. Dementia status was also cross-validated by a
combined neuropathological and clinical consensus report
on 66 centenarians, who consented to neuropsychology
followup and brain donation postmortem [3]. Results are to
be reported elsewhere.
A multinomial logistic response model was fitted to
the study data [13] with SPSS Software at (http://www
.spss.com/). The response was whether or not a centenarian
is a survivor (S), delayer (D), escaper (E), or other (O) with
probability πi j , where i indexes all levels of the independent
variables, sex, race, institutional status, education, body mass
index, use of tobacco (i.e., the ith subpopulation), and
the 11 indicators of chronic diseases found in Figure 1(b)
and j = S, D, E, or O. Using a “[“ for closed and “)”
for open as a standard mathematical notation, a survivor
of chronic diseases is a centenarian who first experiences
chronic diseases in earlier years from [0,80). A delayer is
a centenarian who only first experiences chronic diseases
late in life from [80,98), and an escaper is a centenarian
who only encounters chronic diseases at the very end of life
at 98 or older. These definitions of survivor, delayer, and
escaper diﬀer slightly from those in [4] by using a cutoﬀ of
98 (instead of 100) for the escaper category and by using
a diﬀerent list of chronic diseases in Figure 1(b). For the
multinomial response model here, we use all 11 chronic
diseases in Figure 1(b) to define survivor, delayer, or escaper.
More restrictive definitions for particular disease classes are
also examined in the Results and Discussion (see Table 3).
The log-likelihood is product-multinomial and proportional to
l(B) =

J
m

i

j





ni j ln πi j .

(1)

The cell probabilities πi j are determined by the independent variables and given by


πi j =

exp xi β j

1+

J −1





k=1 exp

xi βk

,

(2)

where xi is the vector of observations on the ith subpopulation and β j is the vector of regression coeﬃcients for
the jth response. The reference response is J. The Other
(O) category arose when there were missing data, and the
reference response was survivor (S). The model was fitted by
the method of maximum likelihood [13].

3. Results and Discussion
Will we be cognitively intact? The prevalence of cognitively
intact centenarians is still being debated. There is broad
variation (27%–100%) in the literature [3] about the
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Table 2: The lifetime prevalences of psychiatric disorders other
than dementia in centenarians versus octogenarian control group
in GCS [3] do not diﬀer.
Disease∗
Dementia
Depression
Anxiety
Psychosis
Total

Octogenarians (%)
13 (14%)∗
14 (17.5%)
5 (6.3%)
1 (1.3%)
33

Centenarians (%)
136 (57%)∗
36 (14.8%)
17 (7.0%)
6 (2.5%)
185

Total #
321
324
324
324
324

∗ The row categories are not mutually exclusive, but dementia tends to be
positively associated with psychiatric disorders (Figure 1(b)). The association of Dementia with age (Control versus Centenarian) is significant with
P < .00001 by Fisher’s Exact test [14] for a 2 × 2 table, but the associations
of Depression, Anxiety, and Psychosis individually with age (Control versus
Centenarian) are not significant with P > .05. If we combine mental health
across Depression, Anxiety, and Psychosis and test for association with age
(Control versus Centenarian) by Fisher’s Exact test [14] for a 2 × 2 table,
the association of the aggregate variable indicating Depression, Anxiety, or
Psychosis with age is not significant. The percents reported in this table are
among 80 octogenarians or 244 centenarians.

prevalence of dementia in centenarians partially due to
diﬀerences in assessment methods and partially due to age,
gender, race, educational attainment ratios, and sampling
techniques (e.g., convenience samples versus populationbased samples). Sampling methods can be vital to the
results when one considers that the functional capacity of
centenarians varies dramatically from one extreme of a
Nobel Laureate [15], Dr. Rita Levi-Montalcini, who serves
currently in the Italian Senate, to someone needing the
support of a nursing home. A Global Deterioration Scale
(GDRS) battery [12] was administered to GCS participants.
Dementia is scored when an individual receives a score of 4–
7 on the GDRS. As shown in Figure 1(d), approximately half
of centenarians (57%) scored as having dementia, while the
majority of octogenarians were cognitively intact.
What will be our emotional state once we reach 100? Based
on a health history questionnaire, centenarians do not appear
to experience more depression, anxiety, or psychoses relative
to octogenarian controls (Table 2). This is surprising because
the prevalence of dementia, which is associated with psychiatric and neurological diseases (Figure 1(b)), is significantly
higher in centenarians versus octogenarians (Figure 1(d)).
To validate concurrently these findings, centenarians and the
control group were compared on the Geriatric Depression
Scale (GDS) [6] short form (Figure 2(f)). The short form
GDS has a range from 1 to 15, with 6–10 suggestive of
depression and 11–15 almost always indicative of depression.
In Figure 2(f), there is a significant diﬀerence by a t-test
(t = 3.68, df = 296, P < .001) in the mean GDS
between centenarians and octogenarians. What this means
is that while there is no evidence for a diﬀerence in lifetime
prevalences of psychiatric disorders (other than dementia) in
Table 2, there is a subclinical diﬀerence in level of depression.
How likely is it that we will be coping with a chronic disease?
There are three mutually exclusive avenues to 100 in this
study [4]. We can be survivors of chronic diseases in earlier
years from 0–80. Alternatively, we can be delayers and only

Table 3: Avenues by which we reach 100. Centenarians who first
experience chronic disease before 80 are termed survivors. Centenarians who first experience chronic disease in the interval 80–
98 years of age are termed delayers. Centenarians who experience
chronic disease only at 98 or older are termed escapers. (a) Fraction
of survivors, delayers, and escapers in the GCS [3] and NECS [4]
studies. (b) Fraction of survivors, delayers, and escapers in the GCS
and NECS studies when matched on the chronic diseases of NECS.
(c) Fraction of survivors, delayers, and escapers by disease.
(a) Avenue to 100 in GCS (N = 244) and NECS studies (N = 424)

Avenue
GCS
NECS

Survivor (%)
43
38

Delayer (%)
36
42

Escaper (%)
17
19

Outcomes (columns) are not significantly diﬀerent by exact test (P = .27)
[14].
(b) Avenue to 100 in GCS and NECS studies when matched on chronic
diseases

Avenue
GCS
NECS

Survivor (%)
35
38

Delayer (%)
35
42

Escaper (%)
24
19

Outcomes (columns) are not significantly diﬀerent by exact test (P = .14)
[14].
(c) Avenue to 100 in GCS dependent on disease category

Avenue
Survivor (%) Delayer (%) Escaper (%)
Cardiovascular disease
24
39
32
Cancer
11
14
73
Outcomes (columns) are significantly diﬀerent (P < .0001) between disease
categories by an exact test [14].

first experience chronic disease late in life from 80–98, or we
can be escapers and only encounter chronic disease at the
very end of life at 98 or older. The avenue by which we achieve
100 years of age depends on the chronic disease encountered
(Table 3c). There are significantly diﬀerent outcomes with
respect to cardiovascular disease and cancer when it comes
to how we reach 100. For example, cardiovascular disease
(i.e., congestive heart failure, myocardial infarction, high
blood pressure, peripheral vascular disease, stroke, transient
ischemic attack (TIA), or any other heart problems) has
a more even distribution across the three avenues, while
centenarians with cancer are mostly escapers (73%). Both
categories, cardiovascular disease and cancer, aggregate
across 8 or more distinct forms of cardiovascular disease or
cancer.
We compared the avenues to 100 in the New England
Centenarian Study (NECS) and GCS. These two studies
diﬀer in population, sampling methods, and chronic disease categories. Despite these diﬀerences, the NECS [4]
percentage of survivors, delayers, and escapers is 38, 42,
and 19%, respectively in Table 3a, which is similar (not
significantly diﬀerent by an exact test [14] in Table 3a) to
the corresponding percentages in the GCS of 43, 36, and
17%, respectively. Matching to the NECS chronic disease,
selection did not change this outcome (Table 3b). When all
chronic diseases in Figure 1(b) are considered, the fraction
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Figure 2: The factors of cardiovascular disease (a), cancer (b), pneumonia (c), psychiatric disorders (d), and living arrangement (e)
determine the fraction of survivors, delayers, and escapers [4] among centenarians. The observed (in blue) and expected proportions (in
red) track each other in that the logistic multinomial model well predicts the outcome of a being a survivor (S), delayer (D), or escaper (E)
[4]. In panels (a)–(e), a square indicates the presence of a disease and a circle, the absence of a disease. (f). Centenarians were higher (with
mean of 3.21 and standard deviation of 2.56) on the Geriatric Depression Scale (GDS) [6] than the control group of octogenarians (with
mean of 2.13 and standard deviation of 2.62). The proportion (15.5%) of centenarians with GDS from 6–15 is significantly diﬀerent from
that proportion (4.6%) in octogenarians (Z = 3.13, P < .001).
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Table 4: Age at onset of chronic disease and lifetime prevalence
in control group of 80 octogenarians versus 244 centenarians.
To correct for right censoring due to GCS study termination a
stepwise Cox Regression [17] from survival analysis was performed
to estimate average age at onset in centenarians. The average age at
onset from the Cox regression [17] was computed at the mean of
the covariates.
(a)

Disease
Cancer∗
Cardiovascular

Average
Age at
Onset
78±3
83±1

n
22
181

Average Age at
Onset from Cox
regression
60±0.5
77±0.3

n
238
226

∗ Many cancers are absent, and skin cancers were excluded because of their
later onset. The n above diﬀers from the totals in (b) due to missing data.

(b)

Disease
Octogenarians
Centenarians
Total

No cancer
58
171
229

Cancer
22 (28%)
73 (30%)
95 (29%)

Total
80
244
324

A Fisher’s exact test [14] is not significant at α = 0.05, nor is a z-test,
significant, with z = 0.90 on the proportions, 0.28 and 0.30.
(c)

Disease
Octogenarians
Centenarians
Total

No Cardiovascular
19
48
67

Cardiovascular
61 (76%)
196 (80%)
257 (79%)

Total
80
244
324

A Fisher’s exact test [14] is not significant at α = 0.05, nor is a z-test,
significant, with z = 1.80 on the proportions, 0.76 and 0.80.

of escapers is relatively small among centenarians (17–24%
in Table 3). This percentage is also very similar to a Danish
nearly complete longitudinal, 1905 birth cohort study of
successful aging in 40,000 Danes with 19% escapers [16].
Based on these survivorship outcomes and their apparent
stability across three studies, we can make predictions about
the cohort beginning in the year 2060. To do so we add
one more category, the attritor, who never survives to be
a centenarian. For the original cohort yielding the GCS
centenarians, only about 0.0002 became centenarians now,
and 0.9998 are attritors. For the cohort originating in 2060
[1], we would expect that ∼0.5 will live to be centenarians,
that is will not be attritors. Our prediction on the challenge
to entitlement systems in the next century is that the
percentages of escapers, delayers, survivors, and attritors will
be 8.5%, 18%, 21.5%, and 50%, where for example 8.5% =
100 × (0.5) × (0.17). Other factors aﬀecting this prediction
are now discussed.
Both genetic and environmental factors influence successful aging [18–21], particularly the successful outcome
of no chronic diseases until very late in life. Other factors
that might influence the three avenues to 100 include a
participant’s sex, race, institutional status (i.e., living in
the community, PCH, or NH), education, chronic diseases

experienced, body mass index, and smoking. A multinomial
response model was fitted [13] stepwise to data on GCS
centenarians in which the response was a centenarian
classified as survivor, delayer, escaper, or other (missing
data for 8 centenarians), and the independent variables
were sex, race, institutional status, education, tobacco use,
body mass index, and 11 chronic diseases in Figure 1(b)
including dementia. The results in Table 4 and Figures 2(a)–
2(e) display the significant factors (by likelihood ratio test
with significance level of 0.05) to be lifetime prevalence of
psychiatric disorder(s), cardiovascular disease, cancer and
past prevalence of pneumonia as well as institutional status
(i.e., living in the community, PCH, or NH). Goodness of
fit for this multinomial response model is adequate (Pearson
χ 2 = 59.5 with df = 78). The Cox and Snell pseudo-R 2 was
computed [13] as ∼0.39. The influence of these five factors
on the probability of being a survivor, delayer, or escaper is
shown in Figures 2(a)–2(e) as well as the graphical fit of the
model to the data. Being at risk for cardiovascular disease,
cancer, and psychiatric disorders decreases the chance of
becoming a delayer or escaper (Figures 2(a), 2(b), and 2(d)).
Institutional status drops out as significant if the response
categories of survivor and other are collapsed together.
Distal variables, such as level of education, mother’s
education, childhood health, and number of major life events
(marriage, divorce, loss of spouse, etc.) for each centenarian
can have an impact on current health [22]. Only for a subset
of GCS participants (97) were all of these distal variables
available. The number of major life events was significant
(P < .014) in a stepwise fitting procedure to predict a
centenarian’s outcome as survivor, delayer, or escaper (see
Materials and Methods). Goodness of fit remained adequate
with the addition of this distal variable (Pearson χ 2 = 75.9
with df = 90). The Cox and Snell pseudo-R2 increased to 0.51
with this one additional independent variable, indicating
distal variables do help to predict survival outcome.
What chronic diseases will we need to cope with? Individuals in the GCS were characterized by their history
of chronic diseases based on medical histories and an
extensive battery of psychosocial tests. The positive associations (edges) between the 11 most frequent chronic
diseases (nodes) of centenarians are graphically rendered
by multidimensional scaling and network software [9,
10] (Figure 1(b)). There appear to be two clusters of
chronic diseases: one resembles a multicausal cluster having
such common causes/determinants as smoking, imbalanced
nutrition, sedentary lifestyle, and includes cardiovascular
disease, pneumonia, osteoporosis, anemia, and cancer; and
a second cluster including dementia, psychiatric disorders,
and neurological disorders. Those diseases that are connected
are significantly associated by an exact test [14] (α = 0.05)
of diseases X and Y, in which centenarians are classified by
disease status for diseases X and Y in a 2 × 2 table. The two
clusters were independently generated by clustering using
average linkage [11] (Figure 1(c)).
The fact that dementia does not correlate with cardiovascular disease may at first sight seem surprising. This is,
however, not the first time this observation has been made.
In the Nun study [23], dementia did not necessarily correlate
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Table 5: Lifetime Prevalence of chronic diseases among centenarians in the GCS.
Prevalence
Chronic Disease
cardiovascular
dementia
pneumonia
cancer
osteoporosis
psychiatric
anemia
diabetes
kidney
neurological
COPD

Male (%)
27 (73)
15 (41)
15 (41)
14 (38)
1 (3)
2 (5)
5 (14)
3 (8)
7 (19)
4 (11)
2 (5)

Prevalence
Female (%)
169 (82)
121 (60)∗
90 (43)
59 (29)
58 (28)∗∗∗
45 (22)∗
37 (18)
18 (9)
11 (5)∗∗
11 (5)
2 (1)

Pooled over sexes (%)
196 (80)
136 (57)
105 (43)
73 (30)
59 (24)
47 (19)
42 (17)
21 (9)
18 (7)
15 (6)
4 (2)

Number of centenarians
244
240$
244
244
244
244
244
244
244
244
244

∗P

< .05 by Fisher’s Exact Test of disease associated with sex [19]; ∗∗ P < .01 by Fisher’s Exact Test of disease associated with sex [19];∗∗∗ P < .001 by Fisher’s
Exact test of disease associated with sex [19].
$ Four centenarians had missing data.

Distal influences

Proximal influences

Developmental outcomes

Parent’s education

Education

Proximal stress

Childhood health

Individual and
social resources

Health and
survivorship
outcome

Cumulative life
events

Figure 3: Developmental Adaptation: The influence of distal
variables (e.g., cumulative life events, parents’ education, education,
and childhood health) on adaptational outcomes in very late life.

with neuropathology. There are in fact at least two forms
of dementia, Alzheimer’s disease and vascular dementia [24]
with the latter being much less prevalent and correlated with
vascular disease. In centenarians, only 12% of the cases of
dementia were reported as vascular dementia [25]. The low
prevalence of vascular dementia could be one explanation
for the lack of correlation with dementia as scored by the
GDRS in Figure 1(d), which does not distinguish the two
forms of dementia. As discussed in the next section, cancer
and cardiovascular disease have an earlier presentation than
dementia. It is possible that other factors, such as coping
mechanisms with stress and lifestyle (Figure 3), can also
intervene to aﬀect dementia status at 80 years of age and
beyond and weaken the association further.
In some cases, the chronic condition reported in medical histories could be independently validated. For example, diabetes can be independently validated by glycated
Hemoglobin (HbA1C) levels (a cutoﬀ >7% is indicative of

diabetes), and a declaration of diabetes by HbA1c levels
is highly associated with reports from medical histories by
Fisher’s Exact test in both centenarians and octogenarians
(P < .005). As a second example hemoglobin (Hb) levels
(in grams/deciliter or g/dL) were determined on centenarians
and octogenarians. When GCS participants are classified as
anemic using a cutoﬀ of 12 g/dL in females and 13 g/dL
in males, an exact test of association between these two
classifications of GCS participants for anemia is P = .05.
There is underreporting of anemia from medical histories
relative to anemia defined from participant Hb levels.
A summary of the prevalent chronic diseases among centenarians is summarized in Table 5. Cardiovascular disease
and dementia are the most prevalent chronic diseases among
centenarians. For some conditions, such as osteoporosis,
dementia, and psychiatric disorders, the prevalence diﬀers
significantly between the sexes.
When will we experience a chronic disease? For centenarians, the development of chronic diseases varies by type. It
is clear from Figure 1(d) that the prevalence of dementia
rises sharply between the ninth and eleventh decade of life. A
similar question is addressed about age of onset for cancers
and cardiovascular disease among centenarians in Table 4b.
Cancers (with the exception of skin cancers) tend to have
early onset in the eighth decade (seventies) of life, and as a
consequence we saw no diﬀerence in their frequency between
octogenarians and centenarians (Table 4b). In contrast,
cardiovascular disease has a later onset in the ninth decade
of life in GCS (Table 4a). This presents a puzzle for why
there is no diﬀerence in proportions between centenarians
and octogenarians in cardiovascular disease (Table 4b). To
correct for right censoring and to address this puzzle, we
performed a separate Cox-regression analysis [17] on age at
onset for cancer and cardiovascular disease as a function of
the covariates used in the multinomial response modeling
with race being a significant factor in a stepwise Coxregression analysis of cancer age at onset. The eﬀect of
the Cox regression was to shift the estimated means of
cancer and cardiovascular disease earlier to 60 and 77 years
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of age, respectively. The earlier mean onset corrected for
right censoring then explains why in Table 4b there is no
diﬀerence in lifetime prevalence of cardiovascular disease
between octogenarians and centenarians. In that GCS is a
cross-sectional study, there is a need to validate this temporal
pattern of barriers to successful aging being cancer and then
cardiovascular disease in cohort studies [16, 18].
In summary, our data show that there are 11 chronic
diseases that centenarians are likely to experience late in
life. These diseases fall into two morbidity clusters, one
involving such diseases as cardiovascular disease, cancer,
anemia, and osteoporosis, and another cluster associated
with dementia. These chronic diseases pose three major
barriers to successful aging. In their sixties centenarians are
at risk for cancer. In their seventies they are at risk for
cardiovascular disease. In their eighties and beyond they
are at risk for dementia. Approximately half (43%) of the
centenarians did not experience dementia. Approximately
17% of the GCS centenarians escaped chronic disease till
near the end of their life, while 36% delayed the onset
into the 80’s and 90’s and 43% survived chronic diseases
acquired earlier in life (<80 years of age). These proportions
of escapers, delayers, and survivors serve as predictions for
the 2060 cohort with median life expectancy of 100 in
this population. The caveats on such a prediction include
no cohort eﬀects (i.e., war, disease, major health advance,
or changes in the predictors in Figure 2) beyond those
leading to the increase in life expectancy of 2.5 years per
decade. With the exception of dementia, mental health
status did not diﬀer between centenarians and octogenarians,
although levels of depressive symptomatology appeared to be
higher on the GDS scale in centenarians than octogenarians.
Consistent with our model of developmental adaptation
[22] (Figure 3), distal life events contribute to predicting
survivorship outcome. The morbidity classification put forth
by the NECS [4] and current health status are critical
adaptation variables in very late life.
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